Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study.

Multiple lines of evidence suggest that a deficiency of Fragile X Mental Retardation Protein (FMRP) mediates dysfunction of the metabotropic glutamate receptor subtype 5 (mGluR5) in the pathogenesis of fragile X syndrome (FXS), the most commonly known single-gene cause of inherited intellectual disability (ID) and autism spectrum disorder (ASD). Nevertheless, animal and human studies regarding the link between FMRP and mGluR5 expression provide inconsistent or conflicting findings about the nature of those relationships. Since multiple clinical trials of glutamatergic agents in humans with FXS did not demonstrate the amelioration of the behavioral phenotype observed in animal models of FXS, we sought measure if mGluR5 expression is increased in men with FXS to form the basis for improved clinical trials. Unexpectedly marked reductions in mGluR5 expression were observed in cortical and subcortical regions in men with FXS. Reduced mGluR5 expression throughout the living brains of men with FXS provides a clue to examine FMRP and mGluR5 expression in FXS. In order to develop the findings of our previous study and to strengthen the objective tools for future clinical trials of glutamatergic agents in FXS, we sought to assess the possible value of measuring both FMRP levels and mGluR5 expression in men with FXS. We aimed to show the value of measurement of FMRP levels and mGluR5 expression for the diagnosis and treatment of individuals with FXS and related conditions. We administered 3-[18F]fluoro-5-(2-pyridinylethynyl)benzonitrile ([18F]FPEB), a specific mGluR5 radioligand for quantitative measurements of the density and the distribution of mGluR5s, to six men with the full mutation (FM) of FXS and to one man with allele size mosaicism for FXS (FXS-M). Utilizing the seven cortical and subcortical regions affected in neurodegenerative disorders as indicator variables, adjusted linear regression of mGluR5 expression and FMRP showed that mGluR5 expression was significantly reduced in the occipital cortex and the thalamus relative to baseline (anterior cingulate cortex) if FMRP levels are held constant (F(7,47) = 6.84, p < 0.001).These findings indicate the usefulness of cerebral mGluR5 expression measured by PET with [18F]FPEB and FMRP values in men with FXS and related conditions for assessments in community facilities within a hundred-mile radius of a production center with a cyclotron. These initial results of this pilot study advance our previous study regarding the measurement of mGluR5 expression by combining both FMRP levels and mGluR5 expression as tools for meaningful clinical trials of glutamatergic agents for men with FXS. We confirm the feasibility of this protocol as a valuable tool to measure FMRP levels and mGluR5 expression in clinical trials of individuals with FXS and related conditions and to provide the foundations to apply precision medicine to tailor treatment plans to the specific needs of individuals with FXS and related conditions.

Biodegradation of pyridine by the new bacterial isolates S. putrefaciens and B. sphaericus.

In this study, two bacterial strains capable of utilizing pyridine as a sole carbon source were isolated from biofilters. Based on the biochemical test, the organisms were identified as Shewanella putrefaciens and Bacillus sphaericus. In liquid cultures, S. putrefaciens and B. sphaericus degraded pyridine quite effectively up to 500 mg L(-1). S. putrefaciens degrades 500 mg L(-1) of pyridine completely within 140 h, whereas the B. sphaericus degrades 500 mg L(-1) of pyridine only nearly 75% and takes a longer duration of 150 h. S. putrefaciens used pyridine as sole carbon and energy source better than B. sphaericus. Monod's and Haldane's inhibitory growth models were used to obtain maximum specific growth rate (micro(max)), half saturation (K(s)) and substrate inhibition (K(i)) constant for pyridine by using S. putrefaciens and B. sphaericus. The high value of K(i) for S. putrefaciens than B. sphaericus indicates that the inhibition effect can be observed only in a high concentration range. The S. putrefaciens degrades pyridine with a faster rate than B. sphaericus. S. putrefaciens can be used effectively for the treatment of pyridine bearing wastewater and as an inoculum in a biofilter treating pyridine-laden gas.

Performance evaluation and model analysis of BTEX contaminated air in corn-cob biofilter system.

Biofiltration of BTEX with corn-cob packing material have been performed for a period of 68 days in five distinct phases. The overall performance of a biofilter has been evaluated in terms of its elimination capacity by using 3-D mesh techniques. Maximum removal efficiency was found more than 99.85% of all four compounds at an EBRT of 3.06 min in phase I for an inlet BTEX concentration of 0.0970, 0.0978, 0.0971 and 0.0968 g m(-3), respectively. Nearly 100% removal achieved at average BTEX loadings of 20.257 g m(-3) h(-1) to biofilter. A maximum elimination capacity (EC) of 20.239 g m(-3) h(-1) of the biofilter was obtained at inlet BTEX load of 20.391 g m(-3) h(-1). Moreover, using convection-diffusion reaction (CDR) model for biofilter depth shows good agreement with the experimental values for benzene, toluene and ethyl benzene, but for o-xylene the model results deviated from the experimental.

Biological treatment and modeling aspect of BTEX abatement process in a biofilter.

In the present work, a laboratory scale corn-cob based biofilter inoculated with Bacillus sphaericus (MTCC 8103) was used for degradation of BTEX for a period of 86 days. The overall performance of a biofilter evaluated in terms of its elimination capacity by using 3-D mesh technique. Maximum removal efficiency was found more than 96.43% for all four compounds in each phase of experiments. A maximum elimination capacity (EC) of 60.89 gm(-3)h(-1) of the biofilter was obtained at inlet BTEX load of 63.14 gm(-3)h(-1). The follow-up of carbon dioxide concentration profile through the biofilter revealed that the mass ratio of carbon dioxide produced to the BTEX removed was approximately 2.2, which confirms complete degradation of BTEX. Moreover, BTEX concentration profile along the biofilter depth bed also determined by convection-diffusion reactor (CDR) model.

Modelling and computational fluid dynamic behaviour of a biofilter treating benzene.

Biofiltration of an air stream containing benzene has been studied in a laboratory biofilter packed with a mixture of compost, sugar cane bagasse and GAC. In this study, the overall performance of a biofilter has been evaluated in terms of its elimination capacity by using 3-D mesh techniques. The overall results indicate that the agreement between experimental data and estimated model predictions is excellent for benzene. The benzene concentration profiles along the depth of biofilter have also been determined using a convection-diffusion reactor (CDR) model and computational fluid dynamic (CFD) technique. At low flow rates and low concentrations of benzene, the concentration profile throughout the biofilter shows good agreement with CDR model and it becomes more curved and resembles typical decay. Combined analysis of experimental results with CDR model and the CFD shows that the profile of benzene at low concentration becomes more curved and then linear at high concentration. The benzene profiles obtained by CFD are within 5% accuracy of experimental results. The CDR and CFD models are found to be able to predict concentration profiles preciously with depth under the experimental conditions.